A New Kind of MRI Scan for People With Primary CNS Lymphoma
Original title: Feasibility of Acquiring Hyperpolarized Imaging in Patients With Primary CNS Lymphoma
How far along is this research?
This is a trial that is enrolling or has been updated. It is not a finding yet.
This is an early first test in people to see if the scan is safe and workable.
Status: Recruiting. It is looking for patients now. Talk to your care team about whether it fits you.
The trial team last updated this record on . Always check the trial page for the latest.
The short version
This study is testing a special MRI scan to see if it can spot brain lymphoma and show how it responds to treatment.
Who this trial is for. This trial is for people with primary central nervous system lymphoma, a lymphoma that starts in the brain and spinal cord. It is testing an MRI scan that uses a substance called hyperpolarized carbon C 13 pyruvate.
Where it stands. There are no results yet. The team is checking whether this scan can be done, whether it is safe, and whether it helps find the lymphoma and show how it responds to treatment. The answers are not in yet, and the trial has not reported results.
What this means, and what it doesn't
What it could mean: If this scan works, it could one day give doctors a clearer picture of brain lymphoma and how it is responding. That is not known yet. Someone who fits this group can ask their care team whether a study like this makes sense for them.
What it doesn't mean: This does not mean a new scan is ready for you. A trial is a test, not proven care. Joining a trial is not a guarantee of any benefit. And this is not a promise of a cure.
Source: ClinicalTrials.gov, July 14, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.